Related by context. Frequent words. (Click for all words.) 69 phase IIa 68 Phase 1b clinical 67 Phase 2a clinical 67 randomized Phase III 66 placebo controlled clinical 66 multicenter clinical 66 multicentre 65 Phase III clinical 65 Phase 1b trial 65 Phase Ib 65 phase IIb 65 Pivotal Trial 65 Phase 2b clinical 65 dose escalation trial 64 Phase III pivotal 64 Phase 2b trial 64 Phase IIa trial 64 relapsed refractory multiple myeloma 64 Phase Ia 64 EORTC 64 Phase IIb clinical 64 placebo controlled randomized 64 Pivotal Phase III 63 Phase IIb trial 63 multicenter randomized double 63 SPIRIT III 63 confirmatory Phase III 63 multicenter 62 prospective randomized controlled 62 Phase 2a trial 62 Clinical Oncology Annual Meeting 62 randomized controlled clinical 62 Phase III randomized 62 IIa clinical trial 62 Phase IIa clinical 62 pivotal Phase III 62 Phase IIb 62 ATryn R 62 alvimopan 62 diabetic neuropathic pain 62 Phase 2b 62 Phase III 62 axitinib 61 placebo controlled 61 randomized placebo controlled 61 multicenter randomized 61 Clinical Trial Results 61 Phase III Trial 61 Phase 2a 61 randomized clinical 61 prospective observational 61 Azedra 61 Transcatheter Cardiovascular Therapeutics TCT 61 Phase 2b study 61 TRITON TIMI 61 phase 2a 61 CRx 61 Phase IIa 60 tanespimycin 60 Phase 1b 60 retrospective cohort study 60 randomized controlled 60 League Against Rheumatism 60 Phase 1a 60 COPAXONE R 60 Medical Oncology ESMO 60 substudy 60 Phenoptin 59 microplasmin 59 multicenter study 59 double blinded placebo 59 MOZOBIL 59 blind randomized placebo 59 BLA submission 59 prospective randomized 59 registrational 59 blind randomized controlled 59 hepatitis C HCV 59 EuroPCR 59 CR# vcMMAE 59 double blind placebo 58 active comparator 58 TORISEL 58 RTOG 58 HCV protease inhibitor 58 relapsed multiple myeloma 58 Nexavar ® 58 randomized double 58 Proc Natl Acad Sci 58 rNAPc2 58 blinded placebo controlled 58 tesmilifene 58 RGB # 58 Digestive Disease Week DDW 58 single ascending dose 58 EASL 58 Heart Failure Society 58 Completes Enrollment 58 J Clin Oncol 58 ASCO Annual Meeting 58 randomized Phase